Finance

Beta
Lists
CTOR:NASDAQ
Citius Oncology Inc
$0.69
-4.20%
(-0.030) 1D
$0.70
+1.30% (+0.0090)
After hours
Closed: Jul 10, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CTOR...
Open
$0.69
High
$0.71
Low
$0.69
Mkt. cap
64.37M
Avg. vol.
61.49K
Volume
30.99K
52-wk high
$3.18
52-wk low
$0.49
EPS
-$0.47
Beta
3.47
Shares outstanding
92.98M
Open
$0.69
High
$0.71
Low
$0.69
Mkt. cap
64.37M
Avg. vol.
61.49K
Volume
30.99K
52-wk high
$3.18
52-wk low
$0.49
EPS
-$0.47
Beta
3.47
Shares outstanding
92.98M
News stories
From sources across the web
About Citius Oncology Inc
CEO-
Employees-
Founded2021
HeadquartersCranford, New Jersey, United States
SectorBiotechnology
Websitecitiusonc.com
Analyst ratings
Based on 1 analyst giving stock ratings to CTOR in the past 3 months
Buy
Buy
1
Hold
0
Sell
0
12-month forecast
Based on 1 Wall Street analyst offering 12-month price targets for CTOR in the last 3 months
Highest
Current $0.69
$4.00 (+478.87%)
Average
$4.00 (+478.87%)
Lowest
$4.00 (+478.87%)
Analyst
Recommendation
Action
Price target
Projected
Date
Michael Okunewitch
Maxim Group
Buy
Maintained
$4.00
+478.9%
06/02/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
3.94M
1.67M
Cost of goods sold
-
-
789.21K
328.88K
Cost of revenue
-
-
789.21K
328.88K
Research and development expenses
938.28K
1.08M
1.02M
1.08M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
4.01M
3.64M
6.82M
27.15M
Operating expense
4.94M
4.71M
8.41M
29.95M
Total operating expenses
4.94M
4.71M
9.20M
30.28M
Operating income
-4.94M
-4.71M
-5.25M
-28.61M
Other non operating income
-
-
-
1.76M
EBT including unusual items
-5.11M
-4.73M
-5.27M
-26.84M
EBT excluding unusual items
-5.11M
-4.73M
-5.27M
-26.84M
Income tax expense
264.24K
264.24K
264.24K
-231.21K
Effective tax rate
-5.18%
-5.58%
-5.01%
0.86%
Other operating expenses
-
-
-
-
Net income
-5.37M
-5.00M
-5.53M
-26.61M
Net profit margin
-
-
-140.31%
-1,595.98%
Earnings per share
-
-
-
-
Interest and investment income
-
36.37K
28.29K
43.72K
Interest expense
-160.76K
-57.28K
-45.84K
-33.03K
Net interest expenses
-160.76K
-20.90K
-17.55K
10.69K
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-4.68M
-26.89M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer